Medical Science Systems Inc.: The Newport Beach...
Medical Science Systems Inc.: The Newport Beach developer of genetic susceptibility tests for diseases reported a first quarter net loss of $2.2 million, or 39 cents a share, on sales of $58,894. The company completed its initial public stock offering in November.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
